TRULIEVE CANNABIS CORP

Rivers Kim’s disciplined 10(b)(5) sales of Trulieve shares reveal strategic liquidity management, regulatory timing, and a steady outlook for the cannabis firm’s growth.

Trulieve insider sale: CEO Rivers Kim sells 1M shares at $8.30‑$8.75—market calm, liquidity boost, no downside signal. Discover what it means for investors.

Trulieve insider filings reveal a mix of RSU growth, strategic share sales, and option grants, hinting at leadership confidence and potential upside for investors.

Trulieve insider confidence: Christine Hersey’s long‑term RSU hold signals potential upside amid medical‑cannabis growth, regulatory shifts, and cross‑sector opportunities.